Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York

Menerima peserta

Usia 45 hingga 70 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT05080673

Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

University of Rochester Medical Center, Rochester

Menerima pesertaFase 2

Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT07292298

A Phase I-II Study to Test the Safety and Efficacy of PD1 (AB122) and Adenosine Receptor (AB928) Antagonists With Chemotherapy After Short-Course Radiation for Rectal Cancer.

Weill Cornell Medical College, New York
Brooklyn Methodist Hospital - NewYork Presbyterian, New York
New York Presbyterian Hospital - Queens, New York

Menerima pesertaFase 2

Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 29 Jul 2026 · NCT05024097

Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer

Roswell Park Cancer Institute, Buffalo
Memorial Sloan Kettering Commack, Commack
Memorial Sloan Kettering Westchester, Harrison
dan 4 lainnya

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Jul 2026 · NCT06205485

Integrated Cancer Repository for Cancer Research

C.R. Wood Cancer Center, Glens Falls Hospital, Glens Falls
Faxton St. Luke's Healthcare, Mohawk Valley, Utica

Menerima pesertaStudi observasionalSukarelawan sehat diterima

Usia 19 hingga 110 · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT02012699

The Radiation Oncology-Biology Integration Network (ROBIN) Molecular Characterization Trial (MCT) of Standard Short Course Radiotherapy for Rectal Cancer

New York Presbyterian Brooklyn Methodist Hospital, Brooklyn
Weill Cornell Medical College, New York
New York Presbyterian Hospital - Queens, New York

Menerima peserta

Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 15 Jun 2026 · NCT05943210

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

NYU Langone Medical Center, New York

Menerima pesertaFase 1/2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Jun 2026 · NCT06051695

A Study of Response to Standard Treatment Before Surgery in People With Rectal Cancer

Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (Limited protocol activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
dan 1 lainnya

Menerima peserta

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Jun 2026 · NCT06637462

Brodalumab in the Treatment of Immune-Related Adverse Events

Columbia University Irving Medical Center, New York

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Mei 2026 · NCT06673329

A Study of Tucatinib and Trastuzumab in People With Rectal Cancer

Memorial Sloan Kettering Cancer Center at Suffolk - Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
dan 1 lainnya

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Mei 2026 · NCT05672524

Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation

Memorial Sloan Kettering Cancer Center, New York

Menerima pesertaStudi observasional

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Mar 2026 · NCT04668872

Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC)

Columbia University Irving Medical Center, New York

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Feb 2026 · NCT07433673

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Buffalo
Massive Bio SYNERGY-AI site, Hempstead
Massive Bio SYNERGY-AI site, Manhasset
dan 2 lainnya

Menerima pesertaStudi observasional

Semua usia · Semua jenis kelamin · Diperbarui 28 Okt 2025 · NCT03452774

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

NYU Langone Health, New York

Menerima pesertaFase 1/2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2025 · NCT06682793

Feasibility of Non-Operative Management of Rectal Cancer in a Rural Population

Bassett Healthcare Network, Cooperstown

Menerima pesertaStudi observasional

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Mar 2023 · NCT04245683

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.